Conexeu is developing an injectable, thermosensitive ECM scaffold to remodel skin after rapid weight loss, aiming beyond fillers to restore tissue structure.
Miles Harrison
Advertisement
Miles Harrison is the president and CEO of Conexeu Sciences.
Articles by Miles Harrison
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Navigating UV Safety, Photodamage, and Next-Gen Protection: A Q&A With Kathleen Suozzi, MD
2
Dermatology NP Highlights Emerging Therapies and Patient Trust at Elevate-Derm
3
FDA Accepts sBLA for OnabotulinumtoxinA in Masseter Muscle, Pursuing Fifth Aesthetic Indication
4
Elevate-Derm Faculty Highlight Expanding Role of Oral JAK Inhibitors in Pediatric Dermatology
5